IndiaInfoline » Markets » JAGSNPHARM

Jagsonpal Pharmaceuticals Ltd - Share Price

JAGSNPHARM

Open

63.45

Prev. Close

63.45

Turnover (lac.)

32

Day's High

64.50

Day's Low

62.80

52 Week's High

76.05

52 Week's Low

16.25

Book Value

42

Face Value

5

Mkt Cap (Cr.)

166

P/E

16.02

EPS

3.96

Divi. Yield

0.79

Jagsonpal Pharmaceuticals LtdFinancials

Switch to
Consolidated
Standalone

Loading ...

Jagsonpal Pharmaceuticals LtdNews & Updates

Meeting Type

Meeting Date

Resolution Type Description Of Resolution IiAS Recommendation

Peer Comparison

Name LTP PE Mar Cap NP Qtr Div. Yld Sales Qtr BV
Sun Pharmaceuticals Industries Ltd545.8045.38130,763.76724.810.733,207.24106.10
Divis Laboratories Ltd3,671.9054.9696,627.91513.300.441,713.78313.47
Dr Reddys Laboratories Ltd4,874.0032.8480,637.51481.000.523,333.60979.45
Cipla Ltd760.0527.2661,140.71745.640.533,711.03233.61
Aurobindo Pharma Ltd893.0019.5852,092.87801.540.344,425.43246.88

Figures of Market Capital(Mar Cap), Quaterly Net Profit(NP Qtr) and Quaterly Sales(Sales Qtr) are in Cr.

Jagsonpal Pharmaceuticals LtdSummary & Reports

No Company Summary found

Registered Office

T-210 J,Shahpur Jat,New Delhi, New Delhi,110049

Tell. : +91-011-46181100/46109900
Website : http://www.jagsonpal.com
Email : cs@jagsonpal.com

Registrar Office

F-65 1st Floor, Phase-I, New Delhi-110020 INDIA

Tell. : +91-11-41406149-52
Website : www.mcsdel.com
Email : mcsdel@vsnl.com

View

- <

Reco. Price

Jul 01,2020 02:48 PM

Target Price

Target Returns:

0.00%

Result Express

Shareholding Snapshot

Loading ...

Corporate Action

  • Purpose

    Board Meeting

    Exp. Date

    10 Nov 2020

    Annc. Date

    02 Nov 2020

    JAGSONPAL PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Com... More

  • Purpose

    AGM

    Exp. Date

    30 Sep 2020

    Annc. Date

    05 Sep 2020

    Intimation for Notice of 41st Annual General Meeting to be held through Video Conferencing or Other ... More

  • Purpose

    Dividend

    Annc. Date

    29 Jul 2020

    Effective. Date

    22 Sep 2020

    Divi. Type

    Final

    Divi.(%)

    10

    Divi. Amt.

    0.5

    Jagsonpal Pharmaceuticals Ltd has informed BSE that the Board of Directors of the Company at its mee... More